IMCD completes acquisition of remaining 30% of Signet Excipients Private Limited
01 Fevereiro 2024 - 2:00PM
IMCD completes acquisition of remaining 30% of Signet Excipients
Private Limited
ROTTERDAM, The Netherlands (1 February 2024) – IMCD N.V.
("IMCD" or "Company"), a global leading distribution partner, and
formulator of speciality chemicals and ingredients, today announces
that it has successfully completed the acquisition of the remaining
30% shares of Indian speciality chemicals distributor Signet
Excipients Private Limited (“Signet”). The agreement of the
acquisition of Signet was announced on 15 September 2020.
The completion of the acquisition of the remaining 30% interest
was executed on the basis of the share purchase agreement of
September 2020. As IMCD obtained full control over Signet as per
November 2020, this purchase price obligation was included in
IMCD’s reported net debt position and results of Signet are
consolidated in full into the IMCD figures since the November 2020
acquisition date. As a result, this completion, as such, will not
impact the reported leverage or earnings levels of IMCD.
Attached, the full press release in pdf format and the main
visual.
- PR_IMCD completes acquisition remaining 30_ of Signet
- Photo_IMCD completes acquisition remaining 30_ of Signet
IMCD NV (EU:IMCD)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
IMCD NV (EU:IMCD)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
